Apoptosis in MDS: a new perspective.
Mundle
S D
SD
MDS Center, Section of Myeloid Diseases, Department of Medicine, Rush University, Chicago, IL, USA.
D000208:Acute Disease; D017209:Apoptosis; D001854:Bone Marrow Cells / Q000473:pathology*; D016207:Cytokines / Q000502:physiology; D018450:Disease Progression; D053222:Fas Ligand Protein; D006412:Hematopoietic Stem Cells / Q000473:pathology; D006801:Humans; D007249:Inflammation; D007951:Leukemia, Myeloid / Q000473:pathology; D008562:Membrane Glycoproteins / Q000502:physiology; D008954:Models, Biological; D009190:Myelodysplastic Syndromes / Q000473:pathology*; D016196:S Phase; D017154:Stromal Cells / Q000473:pathology; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology; D019014:fas Receptor / Q000502:physiology
D016207:Cytokines; C505661:FASLG protein, human; D053222:Fas Ligand Protein; D008562:Membrane Glycoproteins; D014409:Tumor Necrosis Factor-alpha; D019014:fas Receptor